IRMD Rule 144 Notice: Trust Plans Sale of 100K Shares on 09/17/2025
Rhea-AI Filing Summary
Form 144 filed for IRADIMED CORP (IRMD) reports a proposed sale of 100,000 shares of common stock through Roth Capital Partners on 09/17/2025 with an aggregate market value of $7,076,000. The filing identifies the securities as held by the Phillip Susi 2008 Dynasty Trust, acquired on 01/01/1992, and indicates 2,362,500 shares were acquired by that trust on that date. The total shares outstanding reported in the filing are 12,720,002. The filer certifies there are no undisclosed material adverse facts known to the seller and states there were no sales in the past three months by the selling person.
Positive
- None.
Negative
- None.
Insights
TL;DR: An authorized Form 144 notice records a planned sale of 100,000 IRMD shares by a trust; size is below typical materiality thresholds.
The filing documents a Rule 144 notice for sale through Roth Capital Partners of 100,000 common shares valued at $7,076,000 based on the filers stated market value. The securities are held by the Phillip Susi 2008 Dynasty Trust and were originally acquired on 01/01/1992. With 12,720,002 shares outstanding, the proposed sale represents approximately 0.79% of outstanding shares, which is unlikely to be material to company capitalization on its own. The filer also affirms no undisclosed material adverse information and reports no sales in the prior three months.
TL;DR: Routine insider/trust sale notice filed; disclosure appears complete for a Rule 144 transaction.
The document fulfills Rule 144 disclosure elements: identity of selling account, acquisition history, broker details, number of shares to be sold, approximate sale date, and a representation about material non-public information. The statement that no material adverse information is known is standard. There is no indication of accelerated selling or multiple recent disposals, as the form reports nothing to report for prior three-month sales.